Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Ginecología y obstetricia de México
versión impresa ISSN 0300-9041
Resumen
VALDERRAMA-LOYOLA, Omar; VILLACORTA-ARGAEZ, Alfredo y RIO DE LA LOZA-JIMENEZ, Fernando. Intravenous ferric carboxymaltose injection for treatment iron deficiency anemia in abnormal uterine bleeding. Ginecol. obstet. Méx. [online]. 2019, vol.87, n.6, pp.379-384. Epub 30-Jun-2021. ISSN 0300-9041. https://doi.org/10.24245/gom.v87i6.3025.
OBJECTIVE:
The objective was to evaluate efficacy and safety of rapid, large-dose intravenous (IV) administration of ferric carboxymaltose in correcting iron deficiency anemia due to abnormal uterine bleeding.
MATERIAL AND METHODS:
Quasi-experimental study of intervention, not controlled, with the variety before and after a single group (pretest-posttest) carried out in the Hospital Río de la Loza, Mexico, between May 2014 and September 2018. Inclusion criteria: patients 18 years of age or older with anemia and severe abnormal uterine hemorrhage. Exclusion criteria: transfusion of erythrocyte concentrates or administration of parenteral iron in the eight weeks prior to the study, etc. Study variables: hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin concentration, platelets and concentrations of ferritin and platelets.
RESULTS:
13 patients of 18 obtained an increase of 2 g/dL or greater of hemoglobin, 9 of 18 obtained an increase of 2.5 or greater and only 7 of 18 obtained an increase of 3g/dL or greater, the increases were dependent on the administered dose. The average final serum ferritin was 33.44 mcg/L. There were no serious adverse effects reported.
CONCLUSIONS:
The use of iron carboxymaltose intravenously at high doses is a safe treatment in the correction of iron deficiency anemia secondary to abnormal uterine hemorrhage and in the replenishment of iron stores.
Palabras llave : Ferric carboxymaltose; Iron deficiency anemia; Uterine hemorrhage; Erythrocyte; Parenteral iron; Ferric compounds.